Naslov: | Mitochondrial dysfunction in pancreatic alpha and beta cells associated with type 2 diabetes mellitus |
---|
Avtorji: | ID Grubelnik, Vladimir (Avtor) ID Zmazek, Jan (Avtor) ID Markovič, Rene (Avtor) ID Gosak, Marko (Avtor) ID Marhl, Marko (Avtor) |
Datoteke: | https://www.mdpi.com/2075-1729/10/12/348
RAZ_Grubelnik_Vladimir_2020.pdf (1,63 MB) MD5: 715A06CE86DE8D71511B4477A6F3222E
|
---|
Jezik: | Angleški jezik |
---|
Vrsta gradiva: | Članek v reviji |
---|
Tipologija: | 1.01 - Izvirni znanstveni članek |
---|
Organizacija: | FERI - Fakulteta za elektrotehniko, računalništvo in informatiko FNM - Fakulteta za naravoslovje in matematiko MF - Medicinska fakulteta PEF - Pedagoška fakulteta
|
---|
Opis: | Type 2 diabetes mellitus is a complex multifactorial disease of epidemic proportions. It involves genetic and lifestyle factors that lead to dysregulations in hormone secretion and metabolic homeostasis. Accumulating evidence indicates that altered mitochondrial structure, function, and particularly bioenergetics of cells in different tissues have a central role in the pathogenesis of type 2 diabetes mellitus. In the present study, we explore how mitochondrial dysfunction impairs the coupling between metabolism and exocytosis in the pancreatic alpha and beta cells. We demonstrate that reduced mitochondrial ATP production is linked with the observed defects in insulin and glucagon secretion by utilizing computational modeling approach. Specifically, a 30-40% reduction in alpha cells' mitochondrial function leads to a pathological shift of glucagon secretion, characterized by oversecretion at high glucose concentrations and insufficient secretion in hypoglycemia. In beta cells, the impaired mitochondrial energy metabolism is accompanied by reduced insulin secretion at all glucose levels, but the differences, compared to a normal beta cell, are the most pronounced in hyperglycemia. These findings improve our understanding of metabolic pathways and mitochondrial bioenergetics in the pathology of type 2 diabetes mellitus and might help drive the development of innovative therapies to treat various metabolic diseases. |
---|
Ključne besede: | pancreatic endocrine cells, mathematical model, mitochondrial dysfunction, cellular bioenergetics, diabetes, glucagon, insulin |
---|
Status publikacije: | Objavljeno |
---|
Verzija publikacije: | Objavljena publikacija |
---|
Poslano v recenzijo: | 23.10.2020 |
---|
Datum sprejetja članka: | 10.12.2020 |
---|
Datum objave: | 14.12.2020 |
---|
Založnik: | MDPI |
---|
Leto izida: | 2020 |
---|
Št. strani: | str. 1-16 |
---|
Številčenje: | Vol. 10, no. 12 |
---|
PID: | 20.500.12556/DKUM-90137 |
---|
UDK: | 616.379 |
---|
COBISS.SI-ID: | 43234819 |
---|
DOI: | 10.3390/life10120348 |
---|
ISSN pri članku: | 2075-1729 |
---|
Datum objave v DKUM: | 03.09.2024 |
---|
Število ogledov: | 47 |
---|
Število prenosov: | 3 |
---|
Metapodatki: | |
---|
Področja: | Ostalo
|
---|
:
|
Kopiraj citat |
---|
| | | Skupna ocena: | (0 glasov) |
---|
Vaša ocena: | Ocenjevanje je dovoljeno samo prijavljenim uporabnikom. |
---|
Objavi na: | |
---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |